These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21317584)

  • 21. The future of HIV microbicides: challenges and opportunities.
    Garg AB; Nuttall J; Romano J
    Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities.
    Tolley EE; Severy LJ
    Am J Public Health; 2006 Jan; 96(1):79-83. PubMed ID: 16317214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in microbicide vaginal rings.
    Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
    Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
    Mantell JE; Morar NS; Myer L; Ramjee G
    Am J Public Health; 2006 Jun; 96(6):1073-7. PubMed ID: 16670239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretation of genital findings in microbicide safety trials: review of the 'Photo Atlas for Microbicide Evaluation'.
    Bollen LJ; Kilmarx PH; Tappero JW
    J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3():S156-9. PubMed ID: 16419265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides.
    Fetherston SM; Malcolm RK; Woolfson AD
    Ther Deliv; 2010 Dec; 1(6):785-802. PubMed ID: 22834014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.
    Doncel G; Mauck C
    Curr HIV/AIDS Rep; 2004 Apr; 1(1):25-32. PubMed ID: 16091220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's flowing through the microbicide pipeline. Approaches range from complex to simple.
    AIDS Alert; 2004 May; 19(5):52-4. PubMed ID: 15206353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving preclinical models of HIV microbicide efficacy.
    Roan NR; Münch J
    Trends Microbiol; 2015 Aug; 23(8):445-7. PubMed ID: 26250616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbicide update.
    AIDS Patient Care STDS; 2006 Jun; 20(6):448. PubMed ID: 16789859
    [No Abstract]   [Full Text] [Related]  

  • 31. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L; Liebenberg L; Barnabas S; Passmore JA
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of topical microbicides to prevent the sexual transmission of HIV.
    Buckheit RW; Watson KM; Morrow KM; Ham AS
    Antiviral Res; 2010 Jan; 85(1):142-58. PubMed ID: 19874851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HIV microbicide efforts press on.
    Voelker R
    JAMA; 2006 Aug; 296(7):753-5. PubMed ID: 16905775
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows.
    Marrazzo JM
    Clin Infect Dis; 2013 Mar; 56(6):787-9. PubMed ID: 23243177
    [No Abstract]   [Full Text] [Related]  

  • 36. Anal Douche Practices and Willingness to Use a Rectal Microbicide Enema for HIV Prevention and Associated Factors Among an Internet Sample of HIV-Negative and HIV-Discordant Male Couples in the US.
    Mitchell JW; Sophus AI; Lee JY; Petroll AE
    AIDS Behav; 2016 Nov; 20(11):2578-2587. PubMed ID: 26597502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveats associated with the use of human cervical tissue for HIV and microbicide research.
    Anderson DJ; Pudney J; Schust DJ
    AIDS; 2010 Jan; 24(1):1-4. PubMed ID: 19890206
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbicides and HIV prevention.
    McNeir DK
    Posit Aware; 2002; 13(6):36-7. PubMed ID: 12484335
    [No Abstract]   [Full Text] [Related]  

  • 39. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.
    Lard-Whiteford SL; Matecka D; O'Rear JJ; Yuen IS; Litterst C; Reichelderfer P;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):541-52. PubMed ID: 15097296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays.
    Lopes EG; Moreira DA; Gullón P; Gullón B; Cardelle-Cobas A; Tavaria FK
    J Appl Microbiol; 2017 Feb; 122(2):450-461. PubMed ID: 27862685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.